Article Results (Showing 1 - 8 of 8) RSS Alert
-
Shire settles pending litigation with Barr Laboratories
Shire PLC has settled all pending litigation with a company seeking to market a generic version of Shire's top-selling treatment for attention...
Philadelphia Inquirer, The, 08/15/06 by INQUIRER STAFF · More from publication -
WALL STREET CHOICE: ADHD PATCH APPROVAL MEANS 'FAT' RATING FOR SHIRE
Annie Cheng, J.P. Morgan Stock: Shire Pharmaceuticals Rating: Overweight Price: $49.26 52-week range: $30.28-$50.30 The FDA approved Daytrana...
Medical Marketing and Media, 05/01/06 · More from publication -
SHIRE PHARMA. (SHP).
Shire Pharmaceuticals has called on US regulators to carry out further investigations into the link between attention deficit hyperactivity...
Investors Chronicle, 02/17/06 · More from publication -
Adderall XR effective over long term
A once-daily dose of mixed amphetamine salts (Adderall XR) maintained improvement of ADHD symptoms in children aged 6-12 years during a 24-month...
Clinical Psychiatry News, 07/01/05 by Heidi Splete · More from publication -
[ STATE BRIEFS ]
Doctor, wife indicted over drugs KANSAS CITY, Kan. --- A Leawood doctor and his wife face federal charges of illegally distributing several...
Topeka Capital-Journal, The, 05/02/03 by Capital-Journal · More from publication -
Shire Pharmaceuticals Acquires Roberts.
The UK company gains a strong US presence through a $1 billion stock swap. ANDOVER, UK-BASED Shire Pharmaceuticals plans to dramatically...
Chemical Market Reporter, 08/02/99 by SCHERAGA, DAN · More from publication -
Shire Secures Adderall Material.
SHIRE PHARMACEUTICALS Group has reestablished the raw material for Adderall, a treatment for attention deficit hyperactivity disorder. This...
Chemical Market Reporter, 11/02/98 · More from publication -
Shire Reels Under Explosion.
SHIRE PHARMACEUTICALS INC. suffered a blow to its supply of the pharmaceutical active ingredients for Adderall (amphetamine) and DextroStat...
Chemical Market Reporter, 08/10/98 · More from publication
